Check out BDH Stock Reports on The Economic Times. Complete detailed Stock Analysis for BDH, BDH Earnings Indicators, BDH ...
PHARMACISTS have been told to ration a common heartburn drug until 2027, amid major shortages. The Government has issued serious shortage protocol (SSP) notices for two doses of lansoprazole, ...
BRITS are continuing to face some of the “most severe” shortages of NHS medicines on record. Earlier this week, officials sounded the alarm over two drugs, one to prevent strokes and ...
The early-stage trial of a potential novel nonartemisinin malaria drug found it rapidly killed malaria parasites and was generally well tolerated in infected volunteers, showing it is a promising ...
Observational study results suggest antimalarials may have a broad protective effect against systemic damage in lupus nephritis. Among patients with biopsy-confirmed lupus nephritis, antimalarial ...
Among patients with incident rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) who were new antimalarial users, adherence to antimalarials (≥ 90% of doses) was associated with a lower ...
Malaria is a life-threatening disease caused by Plasmodium parasite species and is largely spread between people through the bites of infected female Anopheles mosquitoes. Insecticide-treated bed nets ...
Faith Oladeji, Lead Moderator; Pharm Desola Arowolo, Lead Consultant to NIPRD on Pharma Industry Technical Support; Pharm Oluwatosin Karimu, NMEP-IMPACT Project; Dr Mercy Aboh, NIPRD Lead, IMPACT ...
For the past quarter-century, the gold standard malaria treatment has been artemisinin combination therapies (ACTs). Yet there are issues of treatment nonadherence and malaria parasite drug resistance ...
Because lupus can cause a lot of different health problems, there are many different kinds of medicines that can treat it. You and your doctors can work together to find the right combination of ...
Malaria is one of public health’s most intractable problems—one that’s poised to get worse in coming years, says Dyann Wirth, Richard Pearson Strong Professor of Infectious Diseases at Harvard T.H.